Creating Future Cell Therapy Miracles Together


As a global leading Contract Development and Manufacturing Organization (CDMO) for Cell and Gene therapy products, Minaris Regenerative Medicine has been offering our clients high value clinical and commercial manufacturing services, development solutions, and technologies for 25 years. 

Download Now:

Capabilities and Capacity in Europe

In this brochure, we present our European capabilities for cell and gene therapy manufacturing and our two state-of-the-art facilities centrally located near Munich, Germany. 

EU Capabilities and Capacity

Elevating Horizons: Building Expansion in Allendale, New Jersey  

Experience the remarkable expansion of our Allendale, New Jersey facilities, showcasing our unwavering success in delivering exceptional clinical and commercial manufacturing for over two decades. Witness the stunning transformation with expansive spaces, cutting-edge design, and state-of-the-art clean rooms and advanced analytical labs. Join forces with us today and seize the opportunity for boundless growth and innovation!

Contact Us


In-House Sterility Testing in Allendale, NJ 

Experience unparalleled quality and reliability as you step into the future with our groundbreaking in-house sterility testing service based in Allendale, New Jersey. Our commitment to excellence sets us apart, and we invite companies to join us on this transformative journey. Elevate your standards with our state-of-the-art service – the future is now, and we welcome collaborations for a new era of excellence!


How Can We Support Your Therapeutic Program?

With a track record of over 100 successful technology transfers and serving clinical manufacturing programs for more than 180 clients, our unparalleled knowledge and expertise set us apart. Discover how we can be a valuable partner to your therapeutic program.

GMP Manufacturing Services 

First Commercial Cell and Gene Therapy Product Manufactured at Minaris Regenerative Medicine in Allendale, NJ.

“The commencement of commercial manufacturing for LYFGENIA represents an important step for the cell and gene therapy industry as it will allow many patients fighting sickle cell disease to benefit from this new, potentially curative medicine. Now, I am pleased to announce that Minaris Regenerative Medicine has commercial manufacturing experience in all three of our regions, Japan, Germany, and now the United States.” - Dr. Hiroto Bando, CEO, Minaris Regenerative Medicine

Read the Announcement Here

Creating Future Cell Therapy Miracles Together 

At Minaris, we are experts for development, clinical, and commercial manufacturing of cell and gene therapies. Together with our partners, we have a vision of creating future cell therapy miracles. This allows us to constantly push the boundaries of medicine to serve patients in need. Watch our video to learn more about how we achieve this.

Learn More About Us

Creating Future Cell Therapy Miracles Together 

For over 20 years, we have served more than 180 clients with outstanding quality and reliability.


Our manufacturing development services help you design efficient and robust manufacturing processes for your cell and gene therapy.

Learn More

GMP Manufacturing

We offer a comprehensive manufacturing experience that is fully compliant with the relevant regional regulatory requirements of our global facilities.

Learn More

Our Global Locations

Mountain View, CA Allendale, NJ Munich, Germany Ottobrunn, Germany Yokohama, Japan